CHENNAI: Pharma major Orchid Chemicals and Pharmaceuticals (Orchid) has reported a turnover and operating income of Rs. 238.73 crore for the quarter ended December 31, 2006, in comparison to Rs. 237.60 crore registered during the corresponding third quarter of the last fiscal. The gross profit before interest, depreciation and tax stood at Rs. 78.11 crore as compared to Rs. 69.76 crore in the year-ago period. The net profit after tax stood at Rs. 28.32 crore against Rs. 28.96 crore of the corresponding quarter of the last fiscal.
The third quarter of this fiscal has witnessed a further consolidation and growth in the U.S. business based on ramp-up of the notable product introductions made earlier. Ceftriaxone, Cefprozil, Cefazolin and Cefoxitin continued to be key growth drivers, says a company release.